FIELD: chemistry.
SUBSTANCE: invention refers to new diphenylasetydione of formula (I): 
as well as to its pharmaceutically acceptable salts. Composition can be used as medical product for hyperlipidemia treatment. Method of its production and intermediate compound for its production is described.
EFFECT: production of new diphenylasetydione which can be used as medical product for hyperlipidemia treatment.
9 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIPHENYLAZETHIDINONES SUBSTITUTED WITH ACIDIC GROUPS, METHOD FOR THEIR PREPARING, MEDICINAL AGENT COMPRISING THEREOF AND THEIR USING | 2003 |
|
RU2287522C2 |
| CYCLIC-SUBSTITUTED DIPHENYLAZETHIDINONES, THEIR USING FOR PREPARING MEDICINE AGENT | 2003 |
|
RU2315754C2 |
| COMPOSITIONS COMPRISING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2 AND METHODS OF USING THEREOF | 2012 |
|
RU2669921C2 |
| CATION-SUBSTITUTED DIPHENYLAZETHIDINONES, METHOD FOR THEIR PREPARING, MEDICINAL AGENTS COMPRISING THESE COMPOUNDS AND THEIR USING | 2003 |
|
RU2315753C2 |
| COMBINED TREATMENT BY A TOLL-LIKE RECEPTOR (TLR7) AGONIST AND A HEPATITIS B VIRUS CAPSID ASSEMBLY INHIBITOR | 2016 |
|
RU2718917C2 |
| DERIVATIVES OF DIPHENYLAZETHIDINONE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING | 2001 |
|
RU2282628C2 |
| β-LACTAMS, METHOD FOR PREPARING INDICATED COMPOUNDS AND SERUM HYPOCHOLESTEROLEMIC AGENTS CONTAINING SUCH COMPOUNDS | 2002 |
|
RU2301799C2 |
| DERIVATIVES OF DIPHENYLAZETHIDINONE, MEDICINAL AGENTS COMPRISING THESE COMPOUNDS AND THEIR USING | 2001 |
|
RU2275370C2 |
| CRYSTALLINE FORM OF BENZYL-BENZENE SGLT INHIBITOR | 2011 |
|
RU2569491C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2015 |
|
RU2733405C2 |
